We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanofluidic Diffraction Grating Technique for DNA Amplification May Replace PCR

By LabMedica International staff writers
Posted on 21 Sep 2016
A team of Japanese biophysicists suggests replacing the RT-PCR (real time polymerase chain reaction) technique with a rapid label-free detection method for real-time DNA amplification using a nanofluidic diffraction grating.

Investigators at Nagoya University (Japan) based their strategy for quantifying DNA amplification in a label-free manner on observations of intensity changes of diffracted light derived from the passage of a laser beam through nanochannels embedded in a microchannel; the ability to diffract the beam is a basic characteristic of nanochannels.

In practice, they fabricated 2.7 micron deep, 200 nanometer wide periodic nanochannels embedded in microchannels, which were etched on fused silica substrates by electron beam lithography, photolithography, and plasma etching. More...
For an incident laser beam they used a modulated 532 nanometer laser to amplify a specific component extracted from random or background noise.

They investigators reported in the August 17, 2016, online edition of the journal Scientific Reports that numerical simulations revealed that the diffracted light intensity change in the nanofluidic diffraction grating was attributed to the change of refractive index. Using the technique, they demonstrated the first case reported to date for label-free detection of real-time DNA amplification, such as specific DNA sequences from tubercle bacilli (TB) and human papillomavirus (HPV). Since the system allowed quantification of the initial concentration of amplified DNA molecules ranging from one femtomolar to one picomolar, the investigators expect that it will offer a new strategy for developing fundamental techniques of medical applications.

"Our system also measures DNA amplification at the relatively low temperature of 34 degrees Celsius and without the need for thermal cycles," said contributing author Dr. Noritada Kaji, associate professor of engineering at Nagoya University. "Because it has the potential to be constructed as a single chip and can detect sample volumes as small as one microliter, which is 100-1,000 times less than conventional detectors are capable of, it is particularly suited to development as a miniaturized form of diagnostics and microbe detection."

Related Links:
Nagoya University


Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DROP-AD in-house collection and extraction protocol and testing procedures (Huber, H., Montoliu-Gaya, L., Brum, W.S. et al.; Nat Med (20256); doi.org/10.1038/s41591-025-04080-0)

At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers

Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.